Pfizer Receive First U.S. Authorization for Emergency Use of COVID-19 Vaccine in Adolescents 12 to 15 years of age
In a Phase 3 trial, the vaccine was 100% effective and generally well tolerated in participants ...
Read more
Tag: BioNTech
PFIZER AND BIONTECH TO PROVIDE COVID-19 VACCINE DOSES FOR OLYMPIC ATHLETES
Pfizer Inc. and BioNTech SE today announced the signing of a Memorandum of Understanding (MoU) with ...
Read more
Pfizer and BioNTech Submit Request to Expand Conditional Marketing Authorization of COMIRNATY® in the EU to Adolescents
Pfizer and BioNTech announced they have submitted a variation to the Conditional Marketing Authorization (CMA) in ...
Read more
Pfizer/BioNTech to supply EU with additional 100 million doses of covid 19 vaccine
Pfizer & BioNTech today announced they will supply an additional 100 million doses of COMIRNATY®, the ...
Read more
PFIZER-BIONTECH demonstrated 100% efficacy and robust antibody responses in a Phase 3 trial in adolescents 12 to 15 years of age
In participants aged 12-15 years old, BNT162b2 demonstrated 100% efficacy and robust antibody responses, exceeding those ...
Read more
EMA APPROVES NEW STORAGE OPTION FOR PFIZER-BIONTECH VACCINE
Pfizer Inc. (NYSE: PFE) and BioNTech SE (Nasdaq: BNTX) announced today that the European Medicines Agency (EMA) approved ...
Read more